TMBIM4 Antibody
Description
Biological Functions of TMBIM4
TMBIM4 serves as a critical anti-apoptotic protein with multifaceted biological roles. Primary among these functions is its ability to inhibit apoptosis induced by both intrinsic and extrinsic apoptotic stimuli, positioning it as a key regulator of cellular death pathways . Beyond its anti-apoptotic activity, TMBIM4 demonstrates significant involvement in calcium homeostasis within cells. Research has established that TMBIM4 can modulate both capacitative Ca²⁺ entry and inositol 1,4,5-trisphosphate (IP3)-mediated Ca²⁺ release, suggesting its role in regulating calcium-dependent cellular processes . This dual functionality in apoptosis inhibition and calcium signaling regulation positions TMBIM4 as a protein of interest in various research contexts, including cell death studies, calcium signaling investigations, and potential therapeutic applications targeting these pathways.
Types of TMBIM4 Antibodies
Multiple variants of TMBIM4 antibodies have been developed to target different epitopes of the protein, with polyclonal rabbit antibodies being particularly common among commercial offerings. These antibodies target various regions of the TMBIM4 protein, including N-terminal, internal, and specific peptide sequences . For instance, some commercially available antibodies recognize epitopes within the N-terminal amino acids 1-30, while others target internal regions or specific peptide sequences such as "LTVAVVVTFY DVYIILQAFI LTTTVFFGLT VYTLQSKKDF SKFGAGLFAL" . Immunogen designs vary between manufacturers, with some using synthesized peptides derived from human TMBIM4 or peptides corresponding to specific amino acid positions (e.g., 121-170) . The diversity in epitope targeting provides researchers with options for detecting different forms or domains of TMBIM4 depending on experimental requirements.
Applications in Research
TMBIM4 antibodies demonstrate versatility across multiple research applications, making them valuable tools in molecular and cellular biology investigations. Common applications include:
-
Western Blotting (WB): TMBIM4 antibodies are routinely validated for Western blot applications, with recommended dilutions typically ranging from 1:500 to 1:2000 .
-
Immunohistochemistry (IHC): These antibodies can be applied in tissue section analysis with typical dilutions of 1:100 to 1:300 .
-
Immunocytochemistry (ICC)/Immunofluorescence (IF): For cellular localization studies, TMBIM4 antibodies can be used at dilutions ranging from 1:50 to 1:200 .
-
ELISA: Enzyme-linked immunosorbent assays employ these antibodies at higher dilutions, typically around 1:5000 .
These applications enable researchers to investigate TMBIM4 expression, localization, and interactions across various experimental contexts, contributing to our understanding of this protein's biological roles and regulatory mechanisms.
Species Reactivity
A key consideration when selecting TMBIM4 antibodies is their cross-species reactivity profile, which varies among commercial offerings. Based on the available data, TMBIM4 antibodies demonstrate confirmed reactivity with human samples across all reported antibodies . Many antibodies also show cross-reactivity with rodent models, particularly mouse and rat samples, making them suitable for comparative studies across species . Some antibodies exhibit broader reactivity profiles, with sequence homology analyses suggesting potential cross-reactivity with samples from cow (93%), dog (93%), guinea pig (93%), horse (93%), rabbit (93%), and other species . The sequence homology data indicates that while human TMBIM4 is the primary target (100% homology with the immunogen), mouse TMBIM4 shows slightly lower homology at 86% . This cross-species reactivity information is valuable for researchers working with animal models or conducting comparative studies across different species.
Role in Apoptosis Regulation
TMBIM4's primary function as an anti-apoptotic protein positions it as a critical regulator in cell death pathways. Research indicates that TMBIM4 can inhibit apoptosis triggered by both intrinsic and extrinsic apoptotic stimuli, suggesting its involvement at multiple points in apoptotic signaling cascades . The protein's name itself—transmembrane BAX inhibitor motif-containing protein 4—hints at its mechanistic relationship with BAX, a pro-apoptotic protein central to mitochondrial outer membrane permeabilization during apoptosis. While the exact molecular mechanisms remain under investigation, TMBIM4's ability to counteract diverse apoptotic signals makes it a protein of interest in cancer research, neurodegenerative disease studies, and other contexts where aberrant apoptosis contributes to pathology.
Calcium Signaling Modulation
Beyond its anti-apoptotic functions, TMBIM4 plays a significant role in calcium homeostasis within cells. Research has established that this protein can modulate both capacitative Ca²⁺ entry and inositol 1,4,5-trisphosphate (IP3)-mediated Ca²⁺ release . This dual regulatory capacity suggests TMBIM4's involvement in maintaining calcium balance across cellular compartments and potentially influencing calcium-dependent signaling pathways. The connection between TMBIM4's calcium regulatory functions and its anti-apoptotic properties remains an area of active research, as calcium dysregulation often precedes or accompanies apoptotic processes. This functional interplay positions TMBIM4 at the intersection of calcium signaling and cell death regulation, highlighting its potential significance in various physiological and pathological contexts.
Validation Methods
TMBIM4 antibodies undergo rigorous validation processes to ensure specificity, sensitivity, and reliability across various experimental applications. Common validation approaches include:
-
Western Blot Analysis: Antibodies are tested against whole cell lysates from various cell lines to confirm target specificity. For example, validation has been performed using A549, COS-7, PC12, and CT26 cell lysates .
-
Purification Methods: Many TMBIM4 antibodies are affinity-purified using peptide affinity chromatography with epitope-specific immunogens, achieving purities greater than 95% as determined by SDS-PAGE analysis .
-
Cross-Reactivity Testing: Antibodies are evaluated against samples from multiple species to establish their reactivity profiles and confirm specificity across different organisms .
-
Multiple Application Testing: Comprehensive validation across various techniques (WB, IHC, ICC, IF, ELISA) ensures the antibodies perform consistently across different experimental contexts .
These validation methods provide researchers with confidence in the specificity and performance of TMBIM4 antibodies, enabling reliable detection and analysis of this protein in various research contexts.
Performance Metrics
The performance of TMBIM4 antibodies varies across applications and manufacturers, with several key metrics worthy of consideration:
Table 1: TMBIM4 Antibody Performance Metrics by Application
| Application | Recommended Dilution Range | Detection Sensitivity | Common Controls |
|---|---|---|---|
| Western Blot | 1:500 - 1:2000 | ~23-72 kDa bands | A549, COS-7, PC12 cells |
| IHC | 1:100 - 1:300 | Tissue-specific staining | Human/mouse tissues |
| ICC/IF | 1:50 - 1:200 | Subcellular localization | Various cell lines |
| ELISA | 1:5000 | Quantitative detection | Purified TMBIM4 |
Manufacturers typically provide detailed performance data for specific applications, including observed molecular weights, optimal dilutions, and validated sample types . Quality metrics also include antibody purity assessments, with many commercial offerings exceeding 95% purity as determined by SDS-PAGE analysis . Additionally, sequence homology analyses provide insights into potential cross-reactivity, with reported homology percentages across species: human (100%), mouse (86%), rat (93%), cow (93%), dog (93%), guinea pig (93%), horse (93%), and rabbit (93%) .
Available Formats
TMBIM4 antibodies are commercially available in various formats to accommodate different research requirements. The predominant format is unconjugated antibodies, typically provided as buffered aqueous glycerol solutions . These primary antibodies are most commonly developed in rabbit hosts as polyclonal antibodies, though some mouse-derived polyclonal antibodies are also available . Commercial offerings vary in quantity, with typical volumes ranging from 50-100 μL per vial and protein amounts of approximately 50 μg . Some manufacturers offer trial sizes for initial testing before committing to larger quantities . While the search results primarily indicate unconjugated formats, the diversity of applications suggests that conjugated variants (such as HRP-conjugated or fluorophore-labeled antibodies) might also be available from some suppliers, though specific information on these formats was limited in the provided search results.
Product Specs
Target Background
- Research has identified residues involved in the ion-conducting pore of TMBIM4, shedding light on the mechanism connecting its diverse functions in calcium signaling and apoptosis. PMID: 28469007
- Human TMBIM4 has been discovered as a novel regulator of focal adhesion dynamics, cell adhesion, and migration by controlling localized calcium-dependent activation of calpain. PMID: 23940116
- TMBIM4 can undergo oligomerization in a pH-dependent manner. Importantly, the monomeric form of TMBIM4 retains its functionality. PMID: 23508950
- Research findings suggest that the interaction between Chlamydia pneumoniae protein CPn0809 and TMBIM4 plays a role in modulating bacterial growth within A549 cells. PMID: 23000903
- Studies indicate that TMBIM4, along with BI-1, exhibits a six-transmembrane topology with cytosolic N and C termini, and a C-terminal reentrant loop. PMID: 22418439
- Stable expression of both viral TMBIM4 (v-TMBIM4) and human TMBIM4 (h-TMBIM4) effectively inhibits apoptosis induced by both intrinsic and extrinsic apoptotic stimuli. Notably, h-TMBIM4 is expressed in all human tissues examined. PMID: 17319741
- Based on the evolutionary conservation of the membrane protein family containing multiple membrane-spanning segments, it is proposed that TMBIM4 may participate in cell death regulation by interacting with proteins of the Bcl-2 family, contributing to tumor metastasis. PMID: 18440869
- Research evidence demonstrates that human TMBIM4 modulates intracellular calcium fluxes induced by both physiological and apoptotic stimuli. PMID: 19553469
Q&A
What is TMBIM4 and why is it significant in cellular biology?
TMBIM4 is a protein encoded by the TMBIM4 gene in humans that functions as an anti-apoptotic protein present in the Golgi apparatus. It helps regulate apoptosis by controlling calcium (Ca²⁺) fluxes, with increased GAAP expression helping prevent programmed cell death . TMBIM4 has been identified as a novel Golgi cation channel that modulates both capacitative Ca²⁺ entry and inositol 1,4,5-trisphosphate (IP3)-mediated Ca²⁺ release .
The protein is highly conserved across eukaryotes and even some bacteria, with viral versions (vGAAP) found in certain strains of vaccinia virus . TMBIM4 is significant because:
-
It is expressed in all human tissues analyzed
-
It plays essential roles in cell viability and resistance to apoptotic stresses
-
It promotes cell migration and invasion
-
It has emerging roles in various pathological conditions including preeclampsia and potentially cancer
What applications are TMBIM4 antibodies commonly used for?
TMBIM4 antibodies serve as critical tools for investigating the protein's expression, localization, and functions across multiple experimental approaches:
| Application | Recommended Dilution | Common Detection Methods |
|---|---|---|
| Western Blotting (WB) | 1:500-1:2000 | Chemiluminescence, fluorescence |
| Immunohistochemistry (IHC) | 1:100-1:300 | DAB visualization |
| Immunocytochemistry (ICC) | 1:50-1:200 | Fluorescent secondary antibodies |
| Immunofluorescence (IF) | 1:50-1:200 | Fluorescent secondary antibodies |
| ELISA | 1:5000 | Colorimetric, fluorescent |
These antibodies have been validated for detection of TMBIM4 in multiple species including human, rat, and mouse samples . The observed molecular weight can vary between approximately 27-72 kDa depending on post-translational modifications and experimental conditions .
What is the recommended protocol for detecting TMBIM4 in tissue samples using immunohistochemistry?
For optimal TMBIM4 detection in tissue sections, the following validated protocol is recommended:
-
Sample preparation: Fix tissue in 4% paraformaldehyde, dehydrate, and embed in paraffin. Prepare 5 μm thick sections .
-
Pretreatment: Perform deparaffinization and hydration, followed by peroxide intimal activation with 3% hydrogen peroxide .
-
Blocking: Seal sections with 5% goat serum (or appropriate normal serum) for 45-60 minutes at room temperature .
-
Primary antibody incubation: Apply anti-TMBIM4 antibody at 1:200 dilution (optimal dilution may vary by antibody source) and incubate overnight at 4°C. Include negative controls using rabbit IgG in 1% BSA/PBS .
-
Secondary antibody and visualization: Incubate with biotinylated secondary antibodies and develop using DAB (3,3'-diaminobenzidine) .
-
Analysis: Capture images using a microscope and analyze positive signals using software like ImageJ .
This protocol has been successfully used to detect TMBIM4 in human placental tissues and can be adapted for other tissue types with appropriate optimization .
How should researchers validate the specificity of a TMBIM4 antibody?
Thorough validation of TMBIM4 antibody specificity should include:
-
Western blot analysis using positive control samples (tissues/cell lines known to express TMBIM4) to confirm detection of the correct molecular weight band.
-
Negative controls including TMBIM4 knockout/knockdown cells generated using CRISPR-Cas9 or siRNA technologies.
-
Peptide competition assays by pre-incubating the antibody with the immunizing peptide to demonstrate signal elimination.
-
Cross-application validation by testing the antibody in multiple applications (WB, IHC, ICC) to ensure consistent performance.
-
Orthogonal validation by comparing protein detection with mRNA expression data from qPCR or RNA-seq.
-
Subcellular localization confirmation - TMBIM4/GAAP should predominantly localize to the Golgi apparatus, which can be verified through co-localization with Golgi markers .
Researchers should document all validation parameters, including antibody source, catalog number, lot number, and detailed experimental conditions to ensure reproducibility.
How can TMBIM4 antibodies be utilized in studying cell invasion and migration mechanisms?
TMBIM4 has been identified as a promoter of cell invasion and migration, making antibodies against this protein valuable tools for investigating these cellular processes. Research has shown that overexpression of TMBIM4 stimulates 3-dimensional proteolytic cell invasion through a mechanism dependent on intracellular hydrogen peroxide accumulation .
A comprehensive approach includes:
-
Expression analysis: Use Western blotting with TMBIM4 antibodies to quantify protein levels in cells with different invasive capacities.
-
Localization studies: Employ immunofluorescence to visualize TMBIM4 distribution in relation to invasion-associated structures.
-
Functional correlation: Combine TMBIM4 immunostaining with invasion assays (e.g., Transwell, 3D matrix degradation) to correlate expression with functional outcomes.
-
Mechanistic investigation: Use TMBIM4 antibodies alongside treatments targeting calcium signaling or hydrogen peroxide production to determine pathway dependencies.
-
In vivo relevance: Analyze TMBIM4 expression in tissue sections from invasive disease models or tumor invasion fronts.
This approach has revealed that TMBIM4 promotes invasion by enhancing mitochondrial metabolism in a hydrogen peroxide-dependent manner, suggesting a novel Golgi-derived mechanism controlling cell invasion .
What role does TMBIM4 play in regulating the NLRP3 inflammasome, and how can this be studied?
TMBIM4 functions as a negative regulator of NLRP3 inflammasome activity, with its deficiency enhancing inflammasome activation and subsequent pyroptosis. Recent research has shown that:
-
TMBIM4 knockout in trophoblast cell lines (HTR-8/SVneo) impairs cell viability, migration, and invasion .
-
TMBIM4 deficiency enhances NLRP3 inflammasome activity and promotes pyroptosis, with or without LPS/ATP treatment .
-
The negative relationship between TMBIM4 expression and NLRP3 inflammatory activity has been verified in preeclampsia placentas .
-
Inhibiting the NLRP3 inflammasome with specific inhibitors like MCC950 alleviates pyroptosis and functional damage in TMBIM4-deficient cells .
To investigate this relationship, researchers can:
-
Use TMBIM4 antibodies for expression analysis in inflammatory conditions
-
Perform co-immunoprecipitation to identify interactions between TMBIM4 and inflammasome components
-
Conduct dual immunofluorescence to visualize co-localization patterns
-
Monitor inflammasome markers (NLRP3, cleaved caspase-1, IL-1β, IL-18) after TMBIM4 modulation
This research suggests TMBIM4 as a potential therapeutic target for inflammasome-mediated inflammatory conditions.
How does TMBIM4 regulate calcium signaling in immune responses?
TMBIM4's role in calcium regulation is particularly significant in immune cell function. Research has revealed that:
-
TMBIM4 is critically required for IgG1+ B cell survival during positive selection in germinal centers .
-
The transcription factor Miz1 (Zbtb17) regulates TMBIM4 expression, as demonstrated by ChIP-seq showing Miz1 enrichment at the TMBIM4 promoter region .
-
TMBIM4 prevents exacerbated IP3 receptor Ca²⁺ release during B cell positive selection, protecting IgG1+ germinal center B cells from death .
-
TMBIM4 expression is induced during the transition from Myc-negative to Myc-positive light zone germinal center B cells .
To study this mechanism:
-
Use TMBIM4 antibodies alongside calcium imaging techniques
-
Perform immunoprecipitation to detect interactions with IP3 receptors
-
Analyze TMBIM4 expression in different immune cell subsets during activation
-
Correlate TMBIM4 levels with calcium flux measurements during B cell receptor signaling
Understanding this regulatory pathway provides insights for tailoring isotype-specific germinal center responses in infection and vaccination strategies .
What are common challenges when using TMBIM4 antibodies and how can they be addressed?
Researchers working with TMBIM4 antibodies may encounter several technical challenges:
| Challenge | Possible Causes | Solutions |
|---|---|---|
| Weak signal | Insufficient antigen, low antibody affinity, inadequate incubation | - Optimize antigen retrieval (try citrate buffer pH 6.0) - Adjust antibody concentration (1:100-1:500 for IHC/IF) - Extend incubation to overnight at 4°C |
| High background | Insufficient blocking, excessive antibody, inadequate washing | - Increase blocking duration (1-2 hours) - Use 3-5% BSA or normal serum - Add additional washing steps with 0.1% Tween-20 in PBS |
| Non-specific bands in WB | Cross-reactivity, sample degradation | - Use more stringent washing conditions - Include protease inhibitors during sample preparation - Test different antibody dilutions (1:500-1:2000) |
| Inconsistent results | Sample variation, antibody degradation | - Use fresh antibody aliquots to avoid freeze-thaw cycles - Standardize sample preparation methods - Include positive controls in each experiment |
For optimal results with immunohistochemistry, researchers should note that TMBIM4 has been successfully detected in human placental cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts using specific fixation and staining protocols .
How can researchers effectively distinguish between different members of the TMBIM family?
The TMBIM protein family includes six members (TMBIM1-6) with structural similarities, making specific detection challenging. To effectively distinguish TMBIM4 from other family members:
-
Select antibodies targeting unique regions: Choose antibodies raised against non-conserved sequences of TMBIM4, particularly from the N-terminal or C-terminal domains.
-
Verify molecular weight: TMBIM4 typically appears around 27 kDa (calculated) to 72 kDa (observed) depending on post-translational modifications , which may differ from other TMBIM proteins.
-
Exploit subcellular localization: TMBIM4/GAAP predominantly localizes to the Golgi apparatus , while other family members have distinct subcellular distributions. Use co-localization with organelle markers to confirm identity.
-
Include knockout/knockdown controls: When possible, include TMBIM4-deficient samples as negative controls to confirm antibody specificity.
-
Complement with transcript analysis: Use isoform-specific primers in RT-PCR to verify protein identification at the mRNA level.
This multi-faceted approach ensures accurate discrimination between closely related TMBIM family members in research applications.
What role does TMBIM4 play in pathological conditions?
TMBIM4 has emerging roles in several pathological conditions:
-
Preeclampsia (PE): TMBIM4 is significantly decreased in PE placenta compared to normal pregnancies. This reduction correlates with impaired trophoblast invasion and migration, suggesting TMBIM4 as a potential PE-associated protein .
-
Inflammatory disorders: TMBIM4 deficiency facilitates NLRP3 inflammasome activation and subsequent pyroptosis, potentially contributing to inflammatory pathologies .
-
Cell invasion mechanisms: TMBIM4 overexpression stimulates 3-dimensional proteolytic cell invasion and enhances cell adhesion and colonization in vivo through hydrogen peroxide-dependent mechanisms . This suggests potential involvement in cancer progression.
-
Immune response regulation: TMBIM4 is critically required for IgG1+ B cell survival during positive selection in germinal centers, indicating its importance in proper immune function .
Researchers can use TMBIM4 antibodies to:
-
Assess expression patterns in disease tissues versus normal controls
-
Correlate expression levels with disease severity or progression
-
Investigate mechanistic pathways in disease models
-
Evaluate potential as a diagnostic marker or therapeutic target
How can researchers investigate the relationship between TMBIM4, mitochondrial respiration, and hydrogen peroxide production?
The connection between TMBIM4, mitochondrial metabolism, and reactive oxygen species represents an emerging area of research. Evidence suggests that TMBIM4 promotes cell invasion by enhancing mitochondrial respiration, leading to hydrogen peroxide accumulation .
A comprehensive investigation approach includes:
-
Expression analysis: Use Western blotting with TMBIM4 antibodies to quantify protein levels in different cellular contexts.
-
Subcellular localization: Perform subcellular fractionation followed by immunoblotting or immunofluorescence microscopy to assess TMBIM4 distribution in relation to mitochondria.
-
Functional assessment: Measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in cells with modulated TMBIM4 expression.
-
ROS detection: Quantify hydrogen peroxide production using specific probes (e.g., Amplex Red) in TMBIM4-overexpressing or deficient cells.
-
Mechanistic investigation: Conduct calcium imaging experiments to determine if TMBIM4-mediated calcium fluxes precede changes in mitochondrial function and ROS production.
-
Pathway validation: Use pharmacological interventions targeting calcium signaling, mitochondrial respiration, or ROS production to establish causality.
This integrated approach will help elucidate how TMBIM4's calcium regulatory functions influence mitochondrial metabolism and subsequent ROS production, potentially contributing to cellular processes such as invasion and migration .
TMBIM4 Antibody: Frequently Asked Questions for Researchers
TMBIM4 (Transmembrane BAX Inhibitor Motif Containing 4), also known as GAAP (Golgi Anti-Apoptotic Protein), is a highly conserved cation channel protein that modulates calcium signaling and apoptotic regulation. This comprehensive FAQ collection addresses key research questions about TMBIM4 antibodies, from basic applications to advanced experimental considerations.
What is TMBIM4 and why is it significant in cellular biology?
TMBIM4 is a protein encoded by the TMBIM4 gene in humans that functions as an anti-apoptotic protein present in the Golgi apparatus. It helps regulate apoptosis by controlling calcium (Ca²⁺) fluxes, with increased GAAP expression helping prevent programmed cell death . TMBIM4 has been identified as a novel Golgi cation channel that modulates both capacitative Ca²⁺ entry and inositol 1,4,5-trisphosphate (IP3)-mediated Ca²⁺ release .
The protein is highly conserved across eukaryotes and even some bacteria, with viral versions (vGAAP) found in certain strains of vaccinia virus . TMBIM4 is significant because:
-
It is expressed in all human tissues analyzed
-
It plays essential roles in cell viability and resistance to apoptotic stresses
-
It promotes cell migration and invasion
-
It has emerging roles in various pathological conditions including preeclampsia and potentially cancer
What applications are TMBIM4 antibodies commonly used for?
TMBIM4 antibodies serve as critical tools for investigating the protein's expression, localization, and functions across multiple experimental approaches:
| Application | Recommended Dilution | Common Detection Methods |
|---|---|---|
| Western Blotting (WB) | 1:500-1:2000 | Chemiluminescence, fluorescence |
| Immunohistochemistry (IHC) | 1:100-1:300 | DAB visualization |
| Immunocytochemistry (ICC) | 1:50-1:200 | Fluorescent secondary antibodies |
| Immunofluorescence (IF) | 1:50-1:200 | Fluorescent secondary antibodies |
| ELISA | 1:5000 | Colorimetric, fluorescent |
These antibodies have been validated for detection of TMBIM4 in multiple species including human, rat, and mouse samples . The observed molecular weight can vary between approximately 27-72 kDa depending on post-translational modifications and experimental conditions .
What is the recommended protocol for detecting TMBIM4 in tissue samples using immunohistochemistry?
For optimal TMBIM4 detection in tissue sections, the following validated protocol is recommended:
-
Sample preparation: Fix tissue in 4% paraformaldehyde, dehydrate, and embed in paraffin. Prepare 5 μm thick sections .
-
Pretreatment: Perform deparaffinization and hydration, followed by peroxide intimal activation with 3% hydrogen peroxide .
-
Blocking: Seal sections with 5% goat serum (or appropriate normal serum) for 45-60 minutes at room temperature .
-
Primary antibody incubation: Apply anti-TMBIM4 antibody at 1:200 dilution (optimal dilution may vary by antibody source) and incubate overnight at 4°C. Include negative controls using rabbit IgG in 1% BSA/PBS .
-
Secondary antibody and visualization: Incubate with biotinylated secondary antibodies and develop using DAB (3,3'-diaminobenzidine) .
-
Analysis: Capture images using a microscope and analyze positive signals using software like ImageJ .
This protocol has been successfully used to detect TMBIM4 in human placental tissues and can be adapted for other tissue types with appropriate optimization .
How should researchers validate the specificity of a TMBIM4 antibody?
Thorough validation of TMBIM4 antibody specificity should include:
-
Western blot analysis using positive control samples (tissues/cell lines known to express TMBIM4) to confirm detection of the correct molecular weight band.
-
Negative controls including TMBIM4 knockout/knockdown cells generated using CRISPR-Cas9 or siRNA technologies.
-
Peptide competition assays by pre-incubating the antibody with the immunizing peptide to demonstrate signal elimination.
-
Cross-application validation by testing the antibody in multiple applications (WB, IHC, ICC) to ensure consistent performance.
-
Orthogonal validation by comparing protein detection with mRNA expression data from qPCR or RNA-seq.
-
Subcellular localization confirmation - TMBIM4/GAAP should predominantly localize to the Golgi apparatus, which can be verified through co-localization with Golgi markers .
Researchers should document all validation parameters, including antibody source, catalog number, lot number, and detailed experimental conditions to ensure reproducibility.
How can TMBIM4 antibodies be utilized in studying cell invasion and migration mechanisms?
TMBIM4 has been identified as a promoter of cell invasion and migration, making antibodies against this protein valuable tools for investigating these cellular processes. Research has shown that overexpression of TMBIM4 stimulates 3-dimensional proteolytic cell invasion through a mechanism dependent on intracellular hydrogen peroxide accumulation .
A comprehensive approach includes:
-
Expression analysis: Use Western blotting with TMBIM4 antibodies to quantify protein levels in cells with different invasive capacities.
-
Localization studies: Employ immunofluorescence to visualize TMBIM4 distribution in relation to invasion-associated structures.
-
Functional correlation: Combine TMBIM4 immunostaining with invasion assays (e.g., Transwell, 3D matrix degradation) to correlate expression with functional outcomes.
-
Mechanistic investigation: Use TMBIM4 antibodies alongside treatments targeting calcium signaling or hydrogen peroxide production to determine pathway dependencies.
-
In vivo relevance: Analyze TMBIM4 expression in tissue sections from invasive disease models or tumor invasion fronts.
This approach has revealed that TMBIM4 promotes invasion by enhancing mitochondrial metabolism in a hydrogen peroxide-dependent manner, suggesting a novel Golgi-derived mechanism controlling cell invasion .
What role does TMBIM4 play in regulating the NLRP3 inflammasome, and how can this be studied?
TMBIM4 functions as a negative regulator of NLRP3 inflammasome activity, with its deficiency enhancing inflammasome activation and subsequent pyroptosis. Recent research has shown that:
-
TMBIM4 knockout in trophoblast cell lines (HTR-8/SVneo) impairs cell viability, migration, and invasion .
-
TMBIM4 deficiency enhances NLRP3 inflammasome activity and promotes pyroptosis, with or without LPS/ATP treatment .
-
The negative relationship between TMBIM4 expression and NLRP3 inflammatory activity has been verified in preeclampsia placentas .
-
Inhibiting the NLRP3 inflammasome with specific inhibitors like MCC950 alleviates pyroptosis and functional damage in TMBIM4-deficient cells .
To investigate this relationship, researchers can:
-
Use TMBIM4 antibodies for expression analysis in inflammatory conditions
-
Perform co-immunoprecipitation to identify interactions between TMBIM4 and inflammasome components
-
Conduct dual immunofluorescence to visualize co-localization patterns
-
Monitor inflammasome markers (NLRP3, cleaved caspase-1, IL-1β, IL-18) after TMBIM4 modulation
This research suggests TMBIM4 as a potential therapeutic target for inflammasome-mediated inflammatory conditions.
How does TMBIM4 regulate calcium signaling in immune responses?
TMBIM4's role in calcium regulation is particularly significant in immune cell function. Research has revealed that:
-
TMBIM4 is critically required for IgG1+ B cell survival during positive selection in germinal centers .
-
The transcription factor Miz1 (Zbtb17) regulates TMBIM4 expression, as demonstrated by ChIP-seq showing Miz1 enrichment at the TMBIM4 promoter region .
-
TMBIM4 prevents exacerbated IP3 receptor Ca²⁺ release during B cell positive selection, protecting IgG1+ germinal center B cells from death .
-
TMBIM4 expression is induced during the transition from Myc-negative to Myc-positive light zone germinal center B cells .
To study this mechanism:
-
Use TMBIM4 antibodies alongside calcium imaging techniques
-
Perform immunoprecipitation to detect interactions with IP3 receptors
-
Analyze TMBIM4 expression in different immune cell subsets during activation
-
Correlate TMBIM4 levels with calcium flux measurements during B cell receptor signaling
Understanding this regulatory pathway provides insights for tailoring isotype-specific germinal center responses in infection and vaccination strategies .
What are common challenges when using TMBIM4 antibodies and how can they be addressed?
Researchers working with TMBIM4 antibodies may encounter several technical challenges:
| Challenge | Possible Causes | Solutions |
|---|---|---|
| Weak signal | Insufficient antigen, low antibody affinity, inadequate incubation | - Optimize antigen retrieval (try citrate buffer pH 6.0) - Adjust antibody concentration (1:100-1:500 for IHC/IF) - Extend incubation to overnight at 4°C |
| High background | Insufficient blocking, excessive antibody, inadequate washing | - Increase blocking duration (1-2 hours) - Use 3-5% BSA or normal serum - Add additional washing steps with 0.1% Tween-20 in PBS |
| Non-specific bands in WB | Cross-reactivity, sample degradation | - Use more stringent washing conditions - Include protease inhibitors during sample preparation - Test different antibody dilutions (1:500-1:2000) |
| Inconsistent results | Sample variation, antibody degradation | - Use fresh antibody aliquots to avoid freeze-thaw cycles - Standardize sample preparation methods - Include positive controls in each experiment |
For optimal results with immunohistochemistry, researchers should note that TMBIM4 has been successfully detected in human placental cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts using specific fixation and staining protocols .
How can researchers effectively distinguish between different members of the TMBIM family?
The TMBIM protein family includes six members (TMBIM1-6) with structural similarities, making specific detection challenging. To effectively distinguish TMBIM4 from other family members:
-
Select antibodies targeting unique regions: Choose antibodies raised against non-conserved sequences of TMBIM4, particularly from the N-terminal or C-terminal domains.
-
Verify molecular weight: TMBIM4 typically appears around 27 kDa (calculated) to 72 kDa (observed) depending on post-translational modifications , which may differ from other TMBIM proteins.
-
Exploit subcellular localization: TMBIM4/GAAP predominantly localizes to the Golgi apparatus , while other family members have distinct subcellular distributions. Use co-localization with organelle markers to confirm identity.
-
Include knockout/knockdown controls: When possible, include TMBIM4-deficient samples as negative controls to confirm antibody specificity.
-
Complement with transcript analysis: Use isoform-specific primers in RT-PCR to verify protein identification at the mRNA level.
This multi-faceted approach ensures accurate discrimination between closely related TMBIM family members in research applications.
What role does TMBIM4 play in pathological conditions?
TMBIM4 has emerging roles in several pathological conditions:
-
Preeclampsia (PE): TMBIM4 is significantly decreased in PE placenta compared to normal pregnancies. This reduction correlates with impaired trophoblast invasion and migration, suggesting TMBIM4 as a potential PE-associated protein .
-
Inflammatory disorders: TMBIM4 deficiency facilitates NLRP3 inflammasome activation and subsequent pyroptosis, potentially contributing to inflammatory pathologies .
-
Cell invasion mechanisms: TMBIM4 overexpression stimulates 3-dimensional proteolytic cell invasion and enhances cell adhesion and colonization in vivo through hydrogen peroxide-dependent mechanisms . This suggests potential involvement in cancer progression.
-
Immune response regulation: TMBIM4 is critically required for IgG1+ B cell survival during positive selection in germinal centers, indicating its importance in proper immune function .
Researchers can use TMBIM4 antibodies to:
-
Assess expression patterns in disease tissues versus normal controls
-
Correlate expression levels with disease severity or progression
-
Investigate mechanistic pathways in disease models
-
Evaluate potential as a diagnostic marker or therapeutic target
How can researchers investigate the relationship between TMBIM4, mitochondrial respiration, and hydrogen peroxide production?
The connection between TMBIM4, mitochondrial metabolism, and reactive oxygen species represents an emerging area of research. Evidence suggests that TMBIM4 promotes cell invasion by enhancing mitochondrial respiration, leading to hydrogen peroxide accumulation .
A comprehensive investigation approach includes:
-
Expression analysis: Use Western blotting with TMBIM4 antibodies to quantify protein levels in different cellular contexts.
-
Subcellular localization: Perform subcellular fractionation followed by immunoblotting or immunofluorescence microscopy to assess TMBIM4 distribution in relation to mitochondria.
-
Functional assessment: Measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in cells with modulated TMBIM4 expression.
-
ROS detection: Quantify hydrogen peroxide production using specific probes (e.g., Amplex Red) in TMBIM4-overexpressing or deficient cells.
-
Mechanistic investigation: Conduct calcium imaging experiments to determine if TMBIM4-mediated calcium fluxes precede changes in mitochondrial function and ROS production.
-
Pathway validation: Use pharmacological interventions targeting calcium signaling, mitochondrial respiration, or ROS production to establish causality.
This integrated approach will help elucidate how TMBIM4's calcium regulatory functions influence mitochondrial metabolism and subsequent ROS production, potentially contributing to cellular processes such as invasion and migration .
